AMY FRAZIER: Open Payments
NPI 1912328147 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 1 | $104 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Hemlibra, PENMENVY.
Industry payments across IN — which companies pay providers there.
